advertisement

Topcon

Abstract #77297 Published in IGR 19-3

Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge

Wang JJ; Liu C; Shan K; Shan K; Liu BH; Liu BH; Li XM; Li XM; Zhang SJ; Zhou RM; Zhou RM; Dong R; Dong R; Yan B; Yan B; Sun XH
Theranostics 2018; 8: 3408-3415


Glaucoma is a major cause of visual impairment characterized by progressive retinal neurodegeneration. Circular RNAs are a class of endogenous noncoding RNAs that regulate gene expression in eukaryotes. In this study, we investigated the role of cZNF609 in retinal neurodegeneration induced by glaucoma. qRT-PCR and Sanger sequencing were conducted to detect cZNF609 expression pattern during retinal neurodegeneration. Immunofluorescence staining was conducted to detect the effect of cZNF609 silencing on retinal neurodegeneration in vivo. MTT assay, Ki67 staining, and PI staining were conducted to detect the effect of cZNF609 silencing on retinal glial cells and RGC function in vitro. Bioinformatics analysis, RNA pull-down assays, and in vitro studies were conducted to reveal the mechanism of cZNF609-mediated retinal neurodegeneration. cZNF609 expression was significantly up-regulated during retinal neurodegeneration. cZNF609 silencing reduced retinal reactive gliosis and glial cell activation, and facilitated RGC survival in vivo. cZNF609 silencing directly regulated Müller cell function but indirectly regulated RGC function in vitro. cZNF609 acted as an endogenous miR-615 sponge to sequester and inhibit miR-615 activity, which led to increased METRN. METRN overexpression could partially rescue cZNF609 silencing-mediated inhibitory effects on retinal glial cell proliferation. Intervention of cZNF609 expression is a promising therapeutic strategy for retinal neurodegeneration.

Eye Institute, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.

Full article

Classification:

3.5 Molecular biology incl. SiRNA (Part of: 3 Laboratory methods)
11.8 Neuroprotection (Part of: 11 Medical treatment)



Issue 19-3

Change Issue


advertisement

Oculus